ligand.comLigand Pharmaceuticals Incorporated (LGND)
ligand.com Profile
ligand.com
Sub Domains:investor.ligand.com
Title:Ligand Pharmaceuticals Incorporated (LGND)
Description：News Investors Investor Summary Investor Summary Analysts FAQ News & Events Press Releases Investor Presentations Scientific Presentations IR Calendar Email Alerts Stock Data Quote Charts Historic
Discover ligand.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ligand.com Information
| Website / Domain: | ligand.com |
| HomePage size: | 27.705 KB |
| Page Load Time: | 0.249138 Seconds |
| Website IP Address: | 54.208.101.55 |
| Isp Server: | Amazon.com Inc. |
ligand.com Ip Information
| Ip Country: | United States |
| City Name: | Ashburn |
| Latitude: | 39.043720245361 |
| Longitude: | -77.487487792969 |
ligand.com Keywords accounting
| Keyword | Count |
|---|
ligand.com Httpheader
| Date: Sat, 04 Apr 2020 03:03:36 GMT |
| Server: Apache |
| X-UA-Compatible: IE=Edge |
| Vary: Accept-Encoding |
| Content-Encoding: gzip |
| Content-Length: 5304 |
| Keep-Alive: timeout=5, max=100 |
| Connection: Keep-Alive |
| Content-Type: text/html; charset=UTF-8 |
ligand.com Meta Info
| charset="utf-8"/ |
| content="initial-scale=1.0, width=device-width" name="viewport"/ |
| content="#ffffff" name="msapplication-TileColor"/ |
| content="https://d1io3yog0oux5.cloudfront.net/_c480fa486730dad206f81064c558365d/ligand/files/images/mstile-144x144.png" name="msapplication-TileImage"/ |
| content="https://d1io3yog0oux5.cloudfront.net/_c480fa486730dad206f81064c558365d/ligand/files/images/browserconfig.xml" name="msapplication-config"/ |
| content="#97c21c" name="theme-color"/ |
54.208.101.55 Domains
| Domain | WebSite Title |
|---|
ligand.com Similar Website
| Domain | WebSite Title |
|---|---|
| Ligand Pharmaceuticals Incorporated (LGND) | |
| Investor Summary :: Ligand Pharmaceuticals Incorporated (LGND) | |
| ZUCHE PHARMACEUTICALS PRIVATE LIMITED - Pharmaceuticals,Medical Devices | |
| Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals | |
| Ligand Expo Home | |
| Lifeline Pharmaceuticals, LLCâs Login Page | Lifeline Pharmaceuticals, LLC | |
| Actelion Pharmaceuticals US, Inc | |
| INOVIO Pharmaceuticals | |
| Akorn Pharmaceuticals | |
| Hepion Pharmaceuticals | |
| Home | Pharmaceuticals | |
| Spectrum Pharmaceuticals, Inc. | |
| About Titan Pharmaceuticals Titan Pharmaceuticals Inc | |
| Avadel Pharmaceuticals | |
| Welcome - NeilMed Pharmaceuticals, Inc. |
ligand.com Traffic Sources Chart
ligand.com Alexa Rank History Chart
ligand.com Html To Plain Text
News Investors Investor Summary Investor Summary Analysts FAQ News & Events Press Releases Investor Presentations Scientific Presentations IR Calendar Email Alerts Stock Data Quote Charts Historical Data SEC Filings All SEC Filings Annual Reports Quarterly Reports Section 16 Filings Governance Governance Governance Documents Corporate Responsibility Corporate Responsibility Environmental Social Governance Nasdaq: LGND Home Investors About Overview Management Team Board of Directors Careers Contact Portfolio Summary Overview Marketed Products Portfolio Royalty Table Partners and Licensees Technologies Overview OmniAb Captisol Vernalis Design Platform LTP Technology HepDirect SUREtechnology Licensing Opportunities Business Development Welcome to Ligand Pharmaceuticals Ligand is a high-growth company with economic rights to some of the world's most important medicines. Portfolio Ligand’s portfolio covers a diverse array of therapeutic areas, partners and underlying technologies with many products in late stage development. Learn More Technologies Ligand’s investment in new technology has resulted in cutting-edge innovations that are making major drugs possible. Learn More Licensing Opportunities Ligand has multiple technologies and unpartnered programs available for out-licensing. Learn More Investor Relations View Investor Relations Latest Corporate Presentation Latest News Apr 2, 2020 • 4:02 PM EDT Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs and Ion Channel Technologies Read More Mar 10, 2020 • 8:00 AM EDT Ligand’s Presentation at the Barclays Global Healthcare Conference Now a Webcast Only, New Slides Available on Ligand.com Read More Mar 2, 2020 • 8:00 AM EST Ligand Pharmaceuticals Management to Present at Two Investor Conferences in March Read More Recent Events Mar 16, 2020 • 1:30pm EDT 32nd Annual Roth Conference Dana Point, CA See all events Mar 10, 2020 • 2:35pm EDT Barclays Global Healthcare Conference Miami Beach, FL Webcast See all events Feb 6, 2020 • 4:30pm EDT Ligand Fourth Quarter 2019 Earnings Webcast Webcast See all events Stock Snapshot LGND Nasdaq Volume Market Cap Day Range 52-Week Range © 2020 Ligand Pharmaceuticals Incorporated All Rights Reserved. Privacy Policy Disclaimer Sitemap...
ligand.com Whois
"domain_name": "LIGAND.COM",
"registrar": "Network Solutions, LLC",
"whois_server": "whois.networksolutions.com",
"referral_url": null,
"updated_date": [
"2019-08-13 06:05:12",
"2019-11-04 19:33:51"
],
"creation_date": "1993-10-13 04:00:00",
"expiration_date": "2022-10-12 04:00:00",
"name_servers": [
"NS67.WORLDNIC.COM",
"NS68.WORLDNIC.COM"
],
"status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"emails": [
"abuse@web.com",
"kp7pm33n6dp@networksolutionsprivateregistration.com"
],
"dnssec": "unsigned",
"name": "PERFECT PRIVACY, LLC",
"org": null,
"address": "5335 Gate Parkway care of Network Solutions PO Box 459",
"city": "Jacksonville",
"state": "FL",
"zipcode": "32256",
"country": "US"